These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 420954)

  • 21. A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignancies.
    Shibata SI; Pezner R; Chu D; Doroshow JH; Chow WA; Leong LA; Margolin KA; McNamara MV; Morgan RJ; Raschko JW; Somlo G; Tetef ML; Yen Y; Synold TW; Wagman L; Vora N; Carroll M; Lin S; Longmate J
    Eur J Surg Oncol; 2004 Aug; 30(6):650-7. PubMed ID: 15256240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity.
    Leyva A; van Groeningen CJ; Kraal I; Gall H; Peters GJ; Lankelma J; Pinedo HM
    Cancer Res; 1984 Dec; 44(12 Pt 1):5928-33. PubMed ID: 6498850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study.
    Machover D; Schwarzenberg L; Goldschmidt E; Tourani JM; Michalski B; Hayat M; Dorval T; Misset JL; Jasmin C; Maral R; Mathé G
    Cancer Treat Rep; 1982 Oct; 66(10):1803-7. PubMed ID: 6982099
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancer.
    Villar-Grimalt A; Candel MT; Massuti B; Lizón J; Sánchez B; Frau A; Gorostidi B; Goedkoop R
    Br J Cancer; 1999 May; 80(5-6):786-91. PubMed ID: 10360656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of 5-fluorouracil and cisplatin synergism for advanced gastrointestinal cancers using a collagen gel droplet embedded culture.
    Mori S; Kunieda K; Sugiyama Y; Saji S
    Surg Today; 2003; 33(8):577-83. PubMed ID: 12884094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of combination chemotherapy of aclacinomycin A (ACM) and 5-fluorouracil (5-FU) for advanced carcinoma of gastrointestinal tract].
    Kikuchi K
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):716-21. PubMed ID: 6764110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circadian rhythm-modulated chemotherapy with high dose 5-fluorouracil against gastrointestinal cancers: evaluation and case report.
    Kojima H; Sakamoto J; Yasue M
    Nagoya J Med Sci; 1999 May; 62(1-2):29-38. PubMed ID: 10504825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical studies on 5-fluorouracil suppository for rectal cancer].
    Hayakawa M; Sakuma A; Oouchi A; Takahashi M; Satoh T
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):660-6. PubMed ID: 7184419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of 5-fluorouracil in plasma by GC/MS using an internal standard. Applications to pharmacokinetics.
    Cano JP; Rigault JP; Aubert C; Carcassonne Y; Seitz JF
    Bull Cancer; 1979; 66(1):67-74. PubMed ID: 420949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Fluorouracil in the treatment of gastrointestinal neoplasia.
    N Engl J Med; 1973 Apr; 288(17):910-2. PubMed ID: 4571248
    [No Abstract]   [Full Text] [Related]  

  • 31. Distribution of 5-fluorouracil to body tissues compared after intraluminal, intravenous, and intramural administration in gastrointestinal cancer.
    Shukla HS; Hughes LE; Davis PW; Whitehead RH; Leach KG
    Am J Surg; 1977 Mar; 133(3):346-50. PubMed ID: 848665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion.
    Hillcoat BL; McCulloch PB; Figueredo AT; Ehsan MH; Rosenfeld JM
    Br J Cancer; 1978 Dec; 38(6):719-24. PubMed ID: 743489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-day iv infusion with 5-fluorouracil (5-FU; NSC-19893) for gastroenteric carcinoma after failure on weekly 5-FU therapy.
    Hum GJ; Bateman JR
    Cancer Chemother Rep; 1975; 59(6):1171-9. PubMed ID: 769960
    [No Abstract]   [Full Text] [Related]  

  • 34. The administration of 5-fluorouracil by mouth.
    Bruckner HW; Creasey WA
    Cancer; 1974 Jan; 33(1):14-8. PubMed ID: 4810089
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cancer chemotherapy with futraful suppository for inoperable gastro-intestinal cancer. --Clinical effects with single and combined therapy-- (author's transpl)].
    Misawa S; Ohkuma S; Ide T; Sawai K; Takino T
    Nihon Gan Chiryo Gakkai Shi; 1976 Sep; 11(3):535-45. PubMed ID: 988077
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter: Blood levels of 5-fluorouracil during intravenous infusion.
    Kawai M; Rosenfeld J; McCulloch P; Hillcoat BL
    Br J Cancer; 1976 Mar; 33(3):346-7. PubMed ID: 1268026
    [No Abstract]   [Full Text] [Related]  

  • 37. [5-fluorouracil effectiveness and toxicity in the treatment of digestive trac.t neoplasms as a function of the mode of administration].
    Zelechowska JA; Madej G
    Nowotwory; 1976; 26(1):29-36. PubMed ID: 1257062
    [No Abstract]   [Full Text] [Related]  

  • 38. 5-Fluorouracil: a comparative pharmacokinetic study and preliminary results of a clinical phase I study.
    Obrecht JP; Weber W; Cano JP; Crevoisier C; Alberto P; Forgo I; Heintz R; Germano GH
    Recent Results Cancer Res; 1981; 79():101-7. PubMed ID: 7302355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rationale behind intraperitoneal chemotherapy in gastrointestinal malignancies.
    Speyer JL
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):23-8. PubMed ID: 4048973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of marrow toxicity in patients treated by intravenous infusion of 5 fluorouracil.
    Hillcoat BL; Banerjee M; McCulloch PB; Williams CK
    Eur J Cancer (1965); 1977 Jan; 13(1):81-7. PubMed ID: 844477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.